Le Lézard
Classified in: Health, Business
Subject: FNC

Greenberg Traurig Advises Micron Biomedical in Negotiations with Bill & Melinda Gates Foundation


Life Sciences Company Receives $23.6 Million Grant

ATLANTA, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Greenberg Traurig, LLP advised Micron Biomedical in negotiations with the Bill & Melinda Gates Foundation, which awarded the life sciences company a $23.6 million grant to accelerate the mass production of needle-free vaccines utilizing Micron's proprietary technology.

The Atlanta-based company will use the grant to increase its manufacturing capacity for a measles-rubella vaccine based on its microarray technology which makes administering the vaccine virtually pain-free for children, according to its release. The new technology also reduces the need for cold chain distribution, so the vaccine could be more accessible in developing countries. In 2017, the foundation provided Micron with a grant to fund the first clinical trial of its microarray technology involving children.

The Greenberg Traurig team advising Micron was led by Wayne H. Elowe, shareholder and co-chair of the firm's global Life Sciences and Medical Technology Practice and co-chair of the Atlanta Corporate practice. Atlanta-based Corporate Associate William H. Grossenbacher III also worked on this transaction.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2650 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI "Highly Recommended Law Firm" for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA's Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com

Media Contact

Elaine Walker, Greenberg Traurig, LLP, 3055790832, [email protected], www.gtlaw.com/en

Twitter

SOURCE Greenberg Traurig, LLP


These press releases may also interest you

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...



News published on and distributed by: